Research graph
References from Evidence-domain translation in the Lyme disease controversy over persistent post-treatment symptoms. Local targets link to admitted publications; unresolved targets remain external evidence.
10.23970/ahrqepcwhitepapermachine
10.23970/ahrqepcwhitepapermachine · 2025 · External reference
Lyme disease and the pursuit of a clinical cure
10.3389/fmed.2023.1183344 · 2023 · External reference
Gepa: Reflective prompt evolution can outperform reinforcement learning
10.48550/arxiv.2507.19457 · 2025 · External reference
Ccl19 as a chemokine risk factor for posttreatment lyme disease syndrome: A prospective clinical cohort study
10.1128/cvi.00071-16 · 2016 · External reference
Persistent symptoms after lyme disease: The role of the immune system
10.1093/infdis/jiae203 · 2024 · External reference
Post-treatment lyme syndrome and central sensitization
10.1176/appi.neuropsych.12090223 · 2013 · External reference
Randomized trial of longer-term therapy for symptoms attributed to lyme disease
10.1056/nejmoa1505425 · 2016 · External reference
Evidence assessments and guideline recommendations in lyme disease: The clinical management of known tick bites, erythema migrans rashes and persistent disease
10.1586/14787210.2014.940900 · 2014 · External reference
Development of prompt templates for large language model-driven screening in systematic reviews
10.7326/annals-24-02189 · 2025 · External reference
A comparison of two treatment regimens of ceftriaxone in late lyme disease
10.1007/s00508-005-0361-8 · 2005 · External reference
Antibiotic retreatment of lyme disease in patients with persistent symptoms: A biostatistical review of randomized, placebo-controlled, clinical trials
10.1016/j.cct.2012.08.009 · 2012 · External reference
Title and abstract screening for literature reviews using large language models: An exploratory study in the biomedical domain
10.1186/s13643-024-02575-4 · 2024 · External reference
Treatment of post-treatment lyme disease symptoms—a systematic review
10.1111/ene.16293 · 2024 · External reference
A randomized, placebo-controlled trial of repeated iv antibiotic therapy for lyme encephalopathy
10.1212/01.wnl.0000284604.61160.2d · 2008 · External reference
A critical appraisal of “chronic lyme disease”
10.1056/nejmra072023 · 2007 · External reference
Chatgpt outperforms crowd workers for text-annotation tasks
10.1073/pnas.2305016120 · 2023 · External reference
Aberrant t-cell phenotypes in a cohort of patients with post-treatment lyme disease
10.3389/fimmu.2025.1607619 · 2025 · External reference
GRADE: An emerging consensus on rating quality of evidence and strength of recommendations
10.1136/bmj.39489.470347.ad · 2008 · External reference
On the use of computer-assistance to facilitate systematic mapping
10.1002/cl2.1129 · 2020 · External reference
The environment and disease: Association or causation
10.1177/003591576505800503 · 1965 · External reference
Dspy: Compiling declarative language model calls into self-improving pipelines
10.48550/arxiv.2310.03714 · 2023 · External reference
Treatment trials for post-lyme disease symptoms revisited
10.1016/j.amjmed.2013.02.014 · 2013 · External reference
Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of lyme disease
10.1056/nejm200107123450202 · 2001 · External reference
Study and treatment of post lyme disease (stop-ld) a randomized double masked clinical trial
10.1212/01.wnl.0000071227.23769.9e · 2003 · External reference
Clinical practice guidelines by the infectious diseases society of america (idsa), american academy of neurology (aan), and american college of rheumatology (acr): 2020 guidelines for the prevention, diagnosis and treatment of lyme disease
10.1093/cid/ciaa1215 · 2021 · External reference
Xenodiagnosis to detect Borrelia burgdorferi infection: A first-in-human study
10.1093/cid/cit939 · 2014 · External reference
Persistent symptoms after treatment of lyme disease
10.1016/j.idc.2022.04.004 · 2022 · External reference
Xenodiagnosis to search for Borrelia burgdorferi after antibiotic treatment of lyme disease: A prospective cohort study
10.1093/cid/ciag031 · 2026 · External reference
The peptidoglycan of Borrelia burgdorferi can persist in discrete tissues and cause systemic responses consistent with chronic illness
10.1126/scitranslmed.adr2955 · 2025 · External reference
Optimal large language models to screen citations for systematic reviews
10.1017/rsm.2025.10014 · 2025 · External reference
Duration of antibiotic treatment in disseminated lyme borreliosis: A double-blind, randomized, placebo-controlled, multicenter clinical study
10.1007/s10096-007-0340-2 · 2007 · External reference
Optimizing instructions and demonstrations for multi-stage language model programs
2024 · External reference
Post-treatment lyme disease as a model for persistent symptoms in lyme disease
10.3389/fmed.2020.00057 · 2020 · External reference
External validity of randomised controlled trials: “To whom do the results of this trial apply
10.1016/s0140-6736(04)17670-8 · 2005 · External reference
Large language models for scientometric mapping of scientific controversy: A validated hybrid ai–human framework
10.1007/s11192-026-05681-3 · 2026 · External reference
Prevalence of persistent symptoms after treatment for lyme borreliosis: A prospective observational cohort study
10.1016/j.lanepe.2021.100142 · 2021 · External reference
